DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Insmed.
Safety and Tolerability Study of 2 Dose Level of ArikayceTM in Patients with Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
- Study Results - ClinicalTrials.gov. Accessed January 17, 2021 at:
https://clinicaltrials.gov/ct2/show/results/NCT00775138
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.